The cost of managing multidrug-resistant tuberculosisin an illegal immigrant in Italy

L. Richeldi, K. Floyd, G. B. Migliori, M. Losi, P. Marchegiano, G. Pieroni, L. M. Fabbri, A. Lalvani, M. Raviglione (Modena, Tradate, Modenai, Italy; Geneva, Switzerland; Oxford, United Kingdom)

Source: Annual Congress 2004 - Epidemiology of tuberculosis
Session: Epidemiology of tuberculosis
Session type: Oral Presentation
Number: 4315
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Richeldi, K. Floyd, G. B. Migliori, M. Losi, P. Marchegiano, G. Pieroni, L. M. Fabbri, A. Lalvani, M. Raviglione (Modena, Tradate, Modenai, Italy; Geneva, Switzerland; Oxford, United Kingdom). The cost of managing multidrug-resistant tuberculosisin an illegal immigrant in Italy. Eur Respir J 2004; 24: Suppl. 48, 4315

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The problem of the tuberculosis incidence in health care workers in Ukraine today
Source: Eur Respir J 2002; 20: Suppl. 38, 163s
Year: 2002

MDR-TB in Eastern Europe: new public health interventions
Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis
Year: 2016


Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

The health economics of treating MDR-TB in the Indian private sector
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Risk factors for HIV and multiple drug resistant tuberculosis in civilian and penitentiary sectors in Samara, Russia
Source: Eur Respir J 2003; 22: Suppl. 45, 345s
Year: 2003

Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
Source: Eur Respir J 2012; 40: 133-142
Year: 2012



A study of tuberculosis in an expatriate Nepalese community in South-East London
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public–private initiative
Source: Eur Respir J 2012; 40: 1569-1572
Year: 2012


Particularities and challenges of TB control in homeless in Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration
Source: Eur Respir J 2016; 47: 686-688
Year: 2016


TB endemia – a major priority for public health system in Romania
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems
Source: Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021
Year: 2021



Aspects of effective MDR-TB treatment in the prison hospital, Tomsk (Russia)
Source: Eur Respir J 2006; 28: Suppl. 50, 17s
Year: 2006

Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016



Catastrophic total costs due to tuberculosis among affected households in Uganda; prevalence, drivers and policy implications.
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019

Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Benefits of a municipality tuberculosis screening program among socially vulnerable citizens.
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019